Caffeine

This article examines the diverse applications of caffeine in clinical trials, ranging from its use in treating premature infants to its effects on migraine patients. Caffeine, a widely consumed stimulant, has been studied for its potential benefits in various medical conditions. We’ll explore how researchers are investigating caffeine’s impact on respiratory function, brain activity, metabolic rate, and more.

Table of Contents

What is Caffeine?

Caffeine is a widely used stimulant drug that affects the central nervous system. It is also known by its chemical name, 1,3,7-Trimethylpurine-2,6-dione, or simply as trimethylxanthine[1]. Caffeine is naturally found in coffee beans, tea leaves, and cocoa beans, and is often added to soft drinks and energy drinks. It’s one of the most commonly consumed psychoactive substances in the world.

Caffeine works by blocking adenosine receptors in the brain. Adenosine is a neurotransmitter (a chemical messenger) that promotes sleep and relaxation. By blocking these receptors, caffeine helps to keep you awake and alert[2].

Medical Uses of Caffeine

Caffeine has several medical uses, including:

  • Treatment of apnea in premature infants: Caffeine is routinely given to extremely preterm neonates (babies born before 29 weeks of pregnancy) to prevent pauses in breathing, known as apneas. It’s administered as caffeine citrate and has been shown to potentially reduce the need for a breathing tube in these infants[3].
  • Pain management: Caffeine is sometimes combined with other pain medications like ibuprofen to enhance their pain-relieving effects. This combination has been studied for treating migraines and post-surgical dental pain[4][2].
  • Improving alertness and cognitive function: Caffeine is known to enhance attention and cognitive performance, which is why it’s often used to combat fatigue and improve mental alertness[1].
  • Potential treatment for narcolepsy: Some research is exploring the use of caffeine in managing narcolepsy, a sleep disorder characterized by excessive daytime sleepiness[5].

Effects on the Body

Caffeine has various effects on the body, including:

  • Increased alertness and reduced fatigue: This is the most well-known effect of caffeine[1].
  • Changes in blood flow: Caffeine can reduce resting blood flow in the brain while potentially improving dynamic blood flow regulation[6].
  • Increased metabolic rate: Some studies suggest that caffeine can increase the body’s metabolic rate, which is the rate at which your body burns calories[7].
  • Effects on blood pressure and heart rate: Caffeine can cause a short-term increase in blood pressure and heart rate[1].

Dosage and Administration

The dosage of caffeine varies depending on its use:

  • For premature infants, a typical dose is 20 mg/kg of caffeine citrate[3].
  • For adults, doses used in studies range from 100 mg to 300 mg[1][7].
  • When combined with pain medications, a dose of 100 mg of caffeine is often used[4].

Caffeine can be administered orally in the form of tablets or capsules, or intravenously in medical settings[3].

Side Effects and Safety

While caffeine is generally considered safe for most adults, it can cause side effects, especially in higher doses. These may include:

  • Jitteriness or nervousness
  • Increased heart rate
  • Elevated blood pressure
  • Difficulty sleeping
  • Headaches
  • Gastrointestinal discomfort

It’s important to note that caffeine can be habit-forming, and sudden cessation can lead to withdrawal symptoms in regular users[1].

Drug Interactions

Caffeine can interact with various medications and substances. Some notable interactions include:

  • Amphetamines: Caffeine may enhance the effects of amphetamines[1].
  • Albuterol: Some research is investigating potential synergistic effects between caffeine and albuterol, a medication used to treat asthma[7].
  • Other medications: Caffeine may affect how the body processes certain medications, including some antibiotics and antidepressants.

Always consult with a healthcare provider about potential interactions between caffeine and any medications you’re taking.

Ongoing Research

Caffeine continues to be a subject of extensive research. Some areas of ongoing investigation include:

  • Its potential role in treating narcolepsy[5].
  • Its effects on cerebrovascular reactivity (how blood vessels in the brain respond to stimuli)[6].
  • Its interaction with other substances and medications[8].
  • Its potential synergistic effects with other stimulants or medications[7].

As research continues, our understanding of caffeine’s effects and potential uses in medicine may expand further.

Study Focus Population Key Outcomes Measured
Caffeine in premature infants Extremely preterm infants (< 29 weeks gestation) Respiratory function, brain activity, need for intubation, caffeine pharmacokinetics
Caffeine withdrawal in migraine Adults with migraine Monthly migraine days, withdrawal symptoms, sleep quality
Caffeine and metabolic rate Healthy volunteers Changes in metabolic rate, respiratory quotient, vital signs
Caffeine in cocaine dependence Cocaine-dependent adults Impulsivity, drug discrimination, subjective effects
Caffeine and cerebrovascular reactivity Healthy adults Changes in cerebral and retinal blood flow, cognitive performance

Ongoing Clinical Trials on Caffeine

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated drugs:
    France
  • Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated diseases:
    Czechia Denmark France Germany Italy The Netherlands +3
  • Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Italy Poland +1
  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark Finland France +9

Glossary

  • Apnea of prematurity: A condition in premature infants where they experience pauses in breathing due to their immature respiratory system.
  • Neurovascular coupling (NVC): The relationship between brain activity and changes in blood flow to specific areas of the brain.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Transcranial Doppler (TCD): A non-invasive technique that uses sound waves to measure blood flow velocity in the brain's blood vessels.
  • Functional near-infrared spectroscopy (fNIRS): A neuroimaging method that measures brain activity by detecting changes in blood oxygenation and flow.
  • Dynamic retinal vessel analysis (DVA): A technique to measure changes in the diameter of retinal blood vessels in response to various stimuli.
  • Resting metabolic rate (RMR): The number of calories your body burns while at rest to maintain basic life functions.
  • Respiratory quotient (RQ): The ratio of carbon dioxide produced to oxygen consumed by the body, which indicates which nutrients are being metabolized.
  • Adenosine receptor antagonist: A substance that blocks the effects of adenosine, a neurotransmitter that promotes sleep and suppresses arousal.
  • Heart rate variability (HRV): The variation in time between successive heartbeats, which can indicate the state of the autonomic nervous system.

References

  1. https://clinicaltrials.gov/study/NCT00733993
  2. https://clinicaltrials.gov/study/NCT02863575
  3. https://clinicaltrials.gov/study/NCT01783561
  4. https://clinicaltrials.gov/study/NCT01426971
  5. https://clinicaltrials.gov/study/NCT02832336
  6. https://clinicaltrials.gov/study/NCT04730193
  7. https://clinicaltrials.gov/study/NCT02135965
  8. https://clinicaltrials.gov/study/NCT05594615